Life Sciences Tools and Services
Company Overview of BioClinica, Inc.
BioClinica, Inc. provides integrated clinical research technology solutions to pharmaceutical, biotechnology, medical device companies, and contract research organizations. Its products and services include medical image management, electronic image transport and archive solutions, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools, and clinical trial management software solutions. The company also offers application hosting, consulting, and customer support services. Its clinical trial solutions enable pharmaceutical and biotech companies to collect, clean, process, and store the data generated in clinical trials. T...
826 Newtown-Yardley Road
Newtown, PA 18940-1721
Founded in 1987
Key Executives for BioClinica, Inc.
Senior Vice President of Operations
Executive Vice President and President of eClinical Division
Executive Vice President and President of Imaging Core Lab Division
Compensation as of Fiscal Year 2013.
BioClinica, Inc. Key Developments
Mundipharma Research Selects BioClinica's Onpoint Clinical Trial Management System
Feb 6 14
BioClinica, Inc. has announced that Mundipharma Research has selected BioClinica's OnPoint CTMS, or clinical trial management system. With this decision, Mundipharma Research plans to utilize OnPoint CTMS for various aspects of its clinical trial management activity. OnPoint's Office-Smart capabilities enhance Mundipharma Research's existing investment in Microsoft technologies by letting users access, update, and report on clinical trial data from within the familiar environment of Microsoft Office and SharePoint.
BioClinica, Inc. Plans Continues Investments in its European Workforce
Feb 4 14
BioClinica, Inc. announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology products. The Company plans continued investments in its European workforce in the areas of operations and sales, potentially doubling its European eClinical presence in 2014. The growing team supports BioClinica's full suite of eClinical offerings, including CTMS, EDC, IRT, and clinical supplies planning. Currently, the Company has employees in corporate offices in Lyon, France; Leiden, The Netherlands; and Munich, Germany, with additional personnel in Switzerland, Belgium and the United Kingdom.
Bioclinica, Inc. Announces Successful Completion of First Phase of Big Data Research Project to Develop Novel Algorithms for Automated Analysis of Medical Images in Clinical Trials
Nov 12 13
BioClinica, Inc. announced the successful completion of the first phase of a big data research project to develop novel algorithms for the automated analysis of medical images in clinical trials. This work was made possible by a strategic partnership with the Center for Dynamic Data Analytics (CDDA), a National Science Foundation (NSF) sponsored cooperative research center focused on developing scalable methods for handling large amounts of complex industry-related data. The BioClinica-CDDA project is part of the 'National Big Data and Research and Development Initiative', aimed at addressing the challenges and opportunities of 'Big Data' and is highlighted by the Obama Administration as a high-impact collaboration promoting 'Data to Knowledge to Action.' Under the research project entitled 'Quantitative Tissue Assessment', scientific experts from BioClinica and Rutgers University worked together to define, direct and develop important quantitative tools for the clinical assessment of new therapies for muscle, liver and spleen diseases. These tools enable the extraction of quantitative data from medical images with increased automation and precision. The quantification of muscle tissue is becoming an increasingly important measurement in aging populations for assessing sarcopenia and other musculoskeletal diseases. Additionally, tools for the evaluation of liver and spleen are needed for clinical trials for non-alcoholic steato-hepatitis (NASH) and for a number of orphan diseases. On the heels of the success of the 'Quantitative Tissue Assessment' project, BioClinica and the CDDA have additional projects in the works, including the development of scalable algorithms for automated image analysis for additional therapeutic areas and unmet medical needs.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 16, 2014